Axonal protection achieved in a model of multiple sclerosis using lamotrigine
- 1 December 2006
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (12) , 1542-1551
Abstract
Axonal degeneration is a major cause of permanent disability in multiple sclerosis (MS). Recent observations from our and other laboratories suggest that sodium accumulation within compromised axons is a key, early step in the degenerative process, and hence that limiting axonal sodium influx may represent a mechanism for axonal protection in MS. Here we assess whether lamotrigine, a sodium channel-blocking agent, is effective in preventing axonal degeneration in an animal model of MS, namely chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE). When administered from 7 days post-inoculation, lamotrigine provided a small but significant reduction in the neurological deficit present at the termination of the experiments (averaged over three independent experiments; vehicle: 3.5 ± 2.7; lamotrigine: 2.6 ± 2.0, P < 0.05) and preserved more functional axons in the spinal cord (measured as mean compound action potential area; vehicle: 31.7 μV.ms ± 23.0; lamotrigine: 42.9 ± 27.4, P < 0.05). Histological examination of the thoracic spinal cord (n = 71) revealed that lamotrigine treatment also provided significant protection against axonal degeneration (percentage degeneration in dorsal column; vehicle: 33.5 % ± 38.5; lamotrigine: 10.4 % ± 12.5, P < 0.01). The findings suggest that lamotrigine may provide a novel avenue for axonal protection in MS.Keywords
This publication has 64 references indexed in Scilit:
- Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainideBrain, 2004
- Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAEBrain, 2004
- Nitric oxide and the axonal death cascadeAnnals of Neurology, 2003
- Nitric oxide increases persistent sodium current in rat hippocampal neuronsThe Journal of Physiology, 1999
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Multiple Sclerosis: Symptomatic TherapiesSeminars in Neurology, 1998
- Differential Inhibition by Riluzole, Lamotrigine, and Phenytoin of Sodium and Calcium Currents in Cortical Neurons: Implications for Neuroprotective StrategiesExperimental Neurology, 1997
- Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neuronesBritish Journal of Pharmacology, 1997
- Axonal damage in acute multiple sclerosis lesionsBrain, 1997
- Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neuronesNeuroReport, 1996